ARCHIVES

CERN News 2017 - MEDICIS a new CERN facility

CERN Press release 2017 - MEDICIS une nouvelle installation du CERN

Open Days 2019

MEDICIS-Promed: from fundamental research to hospitals

MEDICIS is restarting after the COVID outbreak

CERN Women In Technology (WIT) Photo Session

PRISMAP: The European medical isotope programme, a consortium with the principal medical radionuclides providers - including MEDICIS - was submitted yesterday for funding by the European Commission; feedback expected after the summer. Link there.

Dr S. Stegemann (ESR-11) receives the Prijs Wetenschap & Innovatie (Prize Science & Innovation) for his PhD thesis from the Faculty of Science of KU Leuven. 

CERN-courrier article: MEDICIS shows its stength - link there.

  •  

PRISMAP-The European medical isotope programme has been selected ! More information there.

  • 01/02/2021

We are welcoming Edgars Mamis from Latvia University, one of the few first PhD students from Latvia at CERN.

  • 04/02/2021

Is the World Cancer Day ! At this occasion, MEDICIS' involvement in the fight against cancer is presented on CERN's official website together with a video of our unique facility.

  • 07/06/2021

MEDICIS is re-starting with a period of maintenance and upgrade !

  • 08/07/2021

Pr. Thomas Cocolios (KU Leuven) receives the "Roger Van Geen" chair! More information here

  • 14/07/2021

Nhat-Tan Vuong (ESR-2) defended his PhD thesis. Congratulations! More information here.

  • 15/07/2021

The article "CERN-MEDICIS: a review since commissioning in 2017" is now published! More information here.

  • 23/09/2021

PRISMAP-The European medical radionuclides programme sets out to substantially change the European landscape for novel and emerging medical radionuclides. More information here.

  • 29/11/2021

The 1st call for user projects of PRISMAP is launched! More information here.

  • 04/02/2022

World cancer day: webinar at 11:30 on MEDICIS mass separation and its impact on theranostics here.

  • 02/05/2022

MEDICIS restarts its program today. Mass separation will be applied to purify and separate Sm-153 from a target produced at BR2. Some details on the project here.

  • 27/05/2022

Plenary presentation on new developments exploiting isotope mass separation in nuclear medicine presented at the 1st AccConf'22 at IAEA.

  • 15/06/2022

1st projects have been selected in PRISMAP-The European medical isotope programme.

  • 06/09/2022

A third collaboration meeting took place today in the French ANR project REPARE, to review the progresses on the development of a high power Bi target for the production of At-211.

NEWS!

  • 09/2024

CERN hosted the 21st Plenay Meeting of the European Observatory on the the Supply of Medical Radionuclides on 25 and 26 of September 2024.

  • 08/2024

Metrology related to medical radioisotopes and MEDICIS is part of the 70th anniversary of CERN-UK relationship celebration on 21st August at NPL.

 

  • 04/2024

The facility restarts for 2024!

  • 02/2024

David Townsend, co-inventor of the PET-CT visited MEDICIS

​D.Townsend at CERN-MEDICIS​

  • 11/2023

Peter Thomson CEO of NPL and colleagues visited MEDICIS and discussed on the metrological aspects important for medical isotopes.

  • 10/2023

The five-years MEDICIS programme and operation was very successfully reviewed by a CERN international review panel.

image0.jpeg

  • 06/2023

MEDICIS recent achievements have been presented during invited presentations at the ARIS2023 conference (Avignon, France) and the 16th conference on nuclear reaction mechanisms (Varenna, Italy)

  • 16/05/2023

Recent technical developments such as the online activity monitoring during implantation and the definition of Key Performance Indicators for MEDICIS were reported at EMIS2022 and IPAC2023 conferences. Related EMIS and IPAC publications.

  • 10/03/2023

Three new project proposals were submitted at the 10th MEDICIS Collaboration board, with a notable request to translate one of the MEDICIS High Molar Activity radionuclides in a clinical settings.

  • 15/11/2022

The Frontiers Research Topics : MEDICIS-Promed, Advances in Radioactive Ion Beams for Nuclear Medicine is now published. It can be downloaded from there.

  • 26/09/2022

The half-life of Tb-155 produced at MEDICIS has been revised and is now published by S. Collins et al. in Applied Radiation and Isotope. High molar activity Sm-153 was 1st used in Targeted Radionuclide Therapy and theranostics (MED-025) by M. Ooms et al, as presented at TERACHEM.

 

JOB OPPORTUNITIES

  • Applied physicist or engineer staff in directorate's office, expertise in particle accelerator technologies and international collaborations, to identify and develop CERN accelerator technology for societal benefit, with a focus on medical fields; more information and to apply click here. ope.

A KNOWLEDGE TRANSFER SUCCESS STORY

Read more ...

GRANTS & DONATIONS - CERN & Society Foundation

The CERN KT-Fund

La Fondation pour l'innovation sur le cancer et la biologie

The ADAM company

The FWO

  PRISMAP and EURAMED in H2020 European commission